Dr Lani Torres-Mapa "Light Delivery Into Optogenetic Biohybrid Cardiac Implants: Challenges, Strategies & Future Directions"
The next Physics Colloquium will be held on Friday 30th November at 11am in Steele Building (03-309).
Speaker Dr. Lani Torres Mapa from Leibniz University (Germany) will be presenting a talk entitled ‘Light Delivery into Optogenetic Biohybrid Cardiac Implant’.
Everyone is welcome to attend!
Dr. Lani Torres-Mapa is a senior researcher with interest in the field of laser manipulation of cells and tissues, optical tweezers and optogenetics. She currently works in the Institute of Quantum Optics in Leibniz University Hannover in Germany.
Title: Light delivery into optogenetic biohybrid cardiac implants: challenges, strategies and future directions
Abstract: Optogenetics has opened new avenues in both basic science and medical research. In cardiovascular research, stimulation using light is an attractive alternative to traditional electrical pacing and restarting of the heart. Light can be shaped and modulated in order to stimulate biological tissues with unprecedented spatial and temporal precision. In this talk, I will provide examples wherein optogenetics may play an invaluable role in the field of cardiac research. I will also discuss our collaborative approaches in order to excite optically activatable biohybrid tissues for cardiac pacing and defibrillation.
About Physics colloquium
The Physics Colloquium series hosts a range of speakers from Australia and abroad. The series explores a variety of topics and everyone is welcome to come along. The seminars are open so there is no need to register your attendance.
If you would like to sign up for colloquium announcement emails, you can join the list at the following:
- For UQ email addresses: https://lists.science.uq.edu.au/mailman/listinfo/physics-colloquium-others
- For non-UQ email addresses: https://lists.science.uq.edu.au/mailman/listinfo/physics-announce-external
(Note: if you receive physics-all emails, you should already receive these and don't need to sign up again).